Ling Zhang

4.1k total citations
107 papers, 2.9k citations indexed

About

Ling Zhang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ling Zhang has authored 107 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 54 papers in Cancer Research and 22 papers in Oncology. Recurrent topics in Ling Zhang's work include Cancer-related molecular mechanisms research (34 papers), RNA modifications and cancer (21 papers) and MicroRNA in disease regulation (21 papers). Ling Zhang is often cited by papers focused on Cancer-related molecular mechanisms research (34 papers), RNA modifications and cancer (21 papers) and MicroRNA in disease regulation (21 papers). Ling Zhang collaborates with scholars based in China, United States and Australia. Ling Zhang's co-authors include Jianping Xiong, Nicholas P. Restifo, Richard A. Morgan, Steven A. Rosenberg, Sid P. Kerkar, Zhili Zheng, Jun Deng, Zhiya Yu, Junhe Li and Xiaojun Xiang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ling Zhang

100 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ling Zhang China	31	1.6k	1.1k	855	641	280	107	2.9k
Arash Salmaninejad Iran	26	1.5k 0.9×	862 0.8×	993 1.2×	818 1.3×	342 1.2×	68	3.1k
Seongho Ryu South Korea	23	1.9k 1.2×	1.1k 1.0×	1.3k 1.5×	571 0.9×	300 1.1×	54	3.3k
Katrina M. Comerford United States	14	1.6k 1.0×	1.5k 1.4×	647 0.8×	772 1.2×	263 0.9×	17	3.5k
Chloé C. Féral France	27	1.6k 1.0×	546 0.5×	888 1.0×	501 0.8×	210 0.8×	59	2.9k
Yunlong Yang China	30	1.5k 1.0×	922 0.9×	993 1.2×	618 1.0×	357 1.3×	62	3.2k
Christine Dubois Belgium	21	1.6k 1.0×	546 0.5×	977 1.1×	359 0.6×	229 0.8×	40	2.8k
Claire M. Dubois Canada	33	1.7k 1.1×	738 0.7×	643 0.8×	764 1.2×	473 1.7×	83	3.8k
Ben Wielockx Germany	30	1.2k 0.8×	1.1k 1.1×	426 0.5×	546 0.9×	162 0.6×	83	2.9k
Peng Wang China	30	2.0k 1.3×	1.2k 1.1×	415 0.5×	444 0.7×	198 0.7×	182	3.1k

Countries citing papers authored by Ling Zhang

Since Specialization

Citations

This map shows the geographic impact of Ling Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Zhang more than expected).

Fields of papers citing papers by Ling Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Zhang. The network helps show where Ling Zhang may publish in the future.

Co-authorship network of co-authors of Ling Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Zhang. A scholar is included among the top collaborators of Ling Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Zhang. Ling Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Jin‐Xing, Ling Zhang, Pengwei Zhang, et al.. (2025). Boanmycin overcomes bortezomib resistance by inducing DNA damage and endoplasmic reticulum functional impairment in multiple myeloma. Biology Direct. 20(1). 1–1.

Zhang, Ling, et al.. (2025). Extracellular Vesicles in Periodontitis: Pathogenic Mechanisms and Therapeutic Potential. Journal of Inflammation Research. Volume 18. 1317–1331. 2 indexed citations

Yang, Lin, Qiong Wu, Ling Zhang, et al.. (2024). Airway microbiota dysbiosis and metabolic disorder in ozone and PM2.5 co-exposure induced lung inflammatory injury in mice. Ecotoxicology and Environmental Safety. 290. 117626–117626. 3 indexed citations

Xiao, Rui, Jiajia Han, Yong‐Jian Deng, et al.. (2024). AGTR1: a potential biomarker associated with the occurrence and prognosis of lung adenocarcinoma. Frontiers in Oncology. 14. 1441235–1441235. 1 indexed citations

Zhang, Ling, et al.. (2023). LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma. Clinical & Translational Oncology. 26(2). 414–423. 1 indexed citations

Zhang, Haoran, Bo Zhang, Qin Wang, et al.. (2020). lncRNA HOTAIR Promotes DNA Repair and Radioresistance of Breast Cancer via EZH2. DNA and Cell Biology. 39(12). 2166–2173. 43 indexed citations

Wang, Mingshu, Anchun Cheng, Qiao Yang, et al.. (2019). Duck Plague Virus Promotes DEF Cell Apoptosis by Activating Caspases, Increasing Intracellular ROS Levels and Inducing Cell Cycle S-Phase Arrest. Viruses. 11(2). 196–196. 14 indexed citations

Li, Junhe, et al.. (2019). UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.. PubMed. 9(9). 1970–1981. 43 indexed citations

Zhang, Ling, et al.. (2019). Knockdown of lncRNA CCEPR suppresses colorectal cancer progression. Experimental and Therapeutic Medicine. 18(5). 3534–3542. 8 indexed citations

10.

Guo, Zhengyang, Mingjie Yao, Yongfeng Wang, et al.. (2018). Diacylglycerol kinase γ predicts prognosis and functions as a tumor suppressor by negatively regulating glucose transporter 1 in hepatocellular carcinoma. Experimental Cell Research. 373(1-2). 211–220. 20 indexed citations

11.

Zhang, Ling, Richard A. Morgan, Joal D. Beane, et al.. (2015). Tumor-Infiltrating Lymphocytes Genetically Engineered with an Inducible Gene Encoding Interleukin-12 for the Immunotherapy of Metastatic Melanoma. Clinical Cancer Research. 21(10). 2278–2288. 332 indexed citations

12.

Zhu, Yu, Xing‐Jun Liu, Ping Yang, et al.. (2014). Alkylglyceronephosphate Synthase (AGPS) Alters Lipid Signaling Pathways and Supports Chemotherapy Resistance of Glioma and Hepatic Carcinoma Cell Lines. Asian Pacific Journal of Cancer Prevention. 15(7). 3219–3226. 31 indexed citations

13.

Zhang, Ling. (2012). Operation of medial temporal lobe epilepsy with hippocampus lesion. 1 indexed citations

14.

Zhang, Ling. (2009). Aidi Injection Combined with Chemotherapy in Advanced Gastric Cancer. 2 indexed citations

15.

Zhang, Ling, et al.. (2009). Kangai injection combined with chemotherapy in advanced gastric cancer.. Zhongliu fangzhi yanjiu. 36(4). 328–330. 2 indexed citations

16.

Liao, Aihua, et al.. (2009). ORIGINAL ARTICLE: Functional Changes of Human Peripheral B‐Lymphocytes in Pre‐Eclampsia. American Journal of Reproductive Immunology. 61(5). 313–321. 20 indexed citations

17.

Zhang, Tao, Ling Zhang, Ji‐Cheng Li, et al.. (2008). Long-term stable expression of antisense cDNA of cyclin B1 profoundly inhibits the proliferation of tumor cells and suppresses tumorigenicity in implanted mice. Chinese Medical Journal. 121(15). 1433–1438. 2 indexed citations

18.

Xu, Nong, et al.. (2007). A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium. BMC Cancer. 7(1). 98–98. 21 indexed citations

19.

Zhang, Ling. (2005). Significance of the imbalance of Th1/Th2 function after acute myocardial infarction. Zhongguo bingli shengli zazhi. 2 indexed citations

20.

Zhang, Ling, Sherven Sharma, Lixia Zhu, et al.. (2003). Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells.. PubMed. 63(16). 5065–72. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact